MAPT and Alzheimer disease: Moreover, our group recently reported that KL‐VSHET attenuates adverse effects of age on memory and executive function26 and cerebrospinal fluid (CSF) tau both cross‐sectionally26 and longitudinally27 in a cognitively unimpaired cohort enhanced for AD risk.